480 likes | 643 Views
Biomedical Catalyst. Dr Helen Kuhlman Lead Technologist, Medicines & Healthcare. Get involved Follow us on twitter @ innovate_uk or join the conversation using #BMC Find innovators on _connect https:// https://connect.innovateuk.org Visit www.innovateuk.org. For more information.
E N D
Biomedical Catalyst Dr Helen Kuhlman Lead Technologist, Medicines & Healthcare Get involved • Follow us on twitter @innovate_uk or join the conversation using #BMC • Find innovators on _connect https:// https://connect.innovateuk.org • Visit www.innovateuk.org
For more information... competitions@innovateuk.org Competition Helpline: 0300 321 4357 www.innovateuk.org _connect Network: https://ktn.innovateuk.org
Joint Technology Strategy Board and Medical Research Council programme investing £180m over 3 years • Deliver growth to the UK life sciences sector through supporting and driving the development of innovative life sciences products and services • Supporting both academically- and commercially-led research and development and encouraging partnership between clinicians, academics and industry • Moving innovative life sciences products and services quicker and more effectively to commercialisation – and ultimately healthcare impact
What do we want to achieve? • Create a more competitive Life Sciences sector in the UK; • Accelerate new products and services onto the market which will have a positive impact on the health of our society; • Lever in significant private investment; • Create new employment opportunities; • Create better synergies and sustained collaborative relationships between the business community and the clinical and academic communities; • Increase the amount of R&D investment in the UK;
Late Stage Award (DCS) Early Stage Award (DPFS) Feasibility Award/CIC Feasibility Award/CIC
Prevention Health Cure Management Detection Outcomes Diagnosis Eligibility SME’s and Academics Individually Collaboratively NOT large business Scope Providing Solutions to Healthcare Challenges, economic growth Any Sector Any Discipline NOT blue skies NOT marketing
Business or Academic Led Application? Technology Strategy Board http://www.innovateuk.org/content/competition/biomedical-catalyst.ashx Medical Research Council http://www.mrc.ac.uk/Ourresearch/ResearchInitiatives/Translationalresearch/index.htm#P24_1233
Status • The Technology Strategy Board was set up in 2007 to support UK economic growth • To do so, we look at the challenges that offer market opportunities, where the UK has real capability and where the timing is right • We work with communities and other organisations to find the right form of support to give companies working in these areas In 4 years.... Over 2000 CR&D projects launched 4000 business partnerships and almost all the UK’s universities Together with partners and business, over £2bn invested in UK innovation
Sustainability Catapults (High Value Manufacturing) (Cell Therapy) (Offshore Renewable Energy) (Satellite Applications) (Connected Digital Economy) Development 2014/15 Energy Built Environment Food Supply Transport Healthcare HighValue Manufacturing Digital Services Advanced Materials Biosciences Electronics, Photonics and Electrical Systems Information and Communications Technology Knowledge Transfer Networks Knowledge Transfer Partnerships SMART
Knowledge Transfer Networks https://connect.innovateuk.org/web/healthktn
£109 billion spent on health care in the UK in 2006/07 69% of the total health and care spend in England is associated with Long Term Conditions... Source: Department of Health (2011) £34 billion spent on the over 65s Photograph by GiulioMazzarini for the Design Council Source: 2010 report to Ofcom by Plum Consulting (Assisted living technologies for older and disabled people in 2030)
Future Health Mission 2012 • 20 UK Health Technology SME’s • Boston trade mission • Investor, supply chain partner and customer meetings • Accelerate your growth potential stateside • Opens today! www.futurehealthmission.com
http://www.innovateuk.org/content/competition/biomedical-catalyst.ashxhttp://www.innovateuk.org/content/competition/biomedical-catalyst.ashx
Feasibility award • evidence gathering to inform decision making • explore and evaluate the commercial potential of an early-stage scientific idea, originating from either academic or industrial research • perform small scale experimental studies, test the market opportunity, identify and develop the route for exploitation Key features: 3 to 12 months Max grant £150k Funded at 75% Single stage process What it’s not! Feasibility awards will not support development activities such as prototyping and are not aimed at supporting small-scale R&D projects where there is no further research and development planned after the end of the project.
Early-stage award Proof of concept in model system 2 stage process Late –stage award applicants face interview panel Late-stage award Demonstrate effectiveness in a relevant environment • Key features: • 1 to 3 years • Max grant per individual £2.4m • Min project size is £250k • SME’s funded at up to 60%
Assessments 3 times a year Dates! Max 1 application per category per round Read the guidance
On demand briefing information: http://t.co/wjKOluHw
Application Process 2 stage (Early & Late Stage) Single Stage (Feasibility) Expression of Interest (EOI) Stage Single Stage Assessment Assessment & Panel Full Stage Assessment & Panel
Application Assessment All applications are assessed by independent reviewers drawn from industry and academia • What do they look for? • Clear and concise answers • The right amount of information • not too much detail • no assumptions • Quantification and justification • That the applicant has the right people with the right bright idea and the means to exploit its potential
The “Ideal Project” • A clear commercial opportunity to open up or exploit a significant growth market. • A technical challenge that requires the creation of an industrially driven project and innovative and risky research and development to solve. • A realistic project with deliverables and applications that are innovative, commercially exploitable and of wider benefit. • A demonstrable need for support.
Gateway Question: Scope How well does the project fit the competition? • Key Points: • “must align” • “clear majority of the projects objectives and activities” • Don’t write yourself out of scope...!
Application Form Feasibility Studies
BMC Feasibility StudiesQuestions 1- 6 Plus appendices
Finance Summary Table • Project Cost Summary • (for each project participant) • 1. Organisation name • 2. Organisation Registration Number • 3. Enterprise Category • 4. Postcode • 5. Contribution to project by each organisation • Funding sought from the Technology Strategy Board • Other Funding from public sector bodies • Total Same for Feasibility and Early & Late Stage EOI
Application Form Early & Late Stage (two stages)
Section 1: All questions are equally weighted (10 marks per question)
Section 2: All questions are equally weighted (10 marks per question)
Section 3: All questions are equally weighted (10 marks per question)
Appendices – Early & Late Stage • Full Stage applications only • These should be used to add justification, graphs, pictures etc to support your application • They are nota continuation of the application form • Do not use web references
Top Tips • Answer the question fully and use all the space available • Number your sections & questions • Check your application for quality of presentation – make the best impression on the assessors • Use capitals when correct to do so but not to draw attention to your case – reviewers do not like it • Quantified means put some numbers in • Avoid clichés – “Holy Grail” or “Market is massive” • Don’t leave your submission until the deadline • Please refer to the Guidance for Applicants
Funding Criteria: Feasibility • Individual or Collaborative... UK business-led • Total eligible project costs funded at 75% • Consortium members (within overall project funding levels) • Industrial (SME) up to 60% • Academic 100% (of 80% FEC)
Funding Criteria: Early & Late • Individual or Collaborative... UK business-led • Individual entity intervention rather than project • SME’s are funded @ up to 60% of their eligible project costs • Academics are funded at 100% of 80%FEC • HOWEVER; the academic portion may not exceed 50% total eligible project costs (collaborations)
Eligible Costs (Industry Partners) • Labour Costs • Overheads • Materials • New Capital Equipment • Existing Capital Equipment Depreciation • Sub-Contracts • Travel & Subsistence • Other Costs • Other eligible direct costs not included in the above headings • Contributions in kind • IP filing costs up to £5,000 (SME only)
Ineligible Project Costs (Industry Partners) • Input or Output VAT • Interest charges, bad debts, profits, advertising, entertainment • Hire purchase interest and associated service charges • Profit earned by a subsidiary or by an associate undertaking work sub-contracted out under the project • Inflation and contingency allowances • The value of existing assets such as IPR, data, software and other exploitable assets that are contributed to the project by any collaborator • Project Audit Fees
Timelines & Offer Letter • Conditional offer letters will be issued approximately 3 weeks after notification. • We will require the return of various documents within the timescales stated on the offer letter to validate the grant offer sent • Financial project cost review and viability checks undertaken • Financial forecast and detailed project plan required • The Project may not start until the organisation has received and returned signed acceptance of the Grant Confirmation Letter
Preparation The Collaboration Agreement Negotiating a Collaboration Agreement can be complex and time consuming. Applicants for Technology Strategy Board funding should therefore start work on this at an early stage in the process, ideally before submitting their full applications
New Projects Workshop • Requirement for successful projects. • Expectation that each partner has one representative to attend the workshop • Outlines process requirements (how to raise a claim etc) • Opportunity to meet your Monitoring Officer
Grant Claims & Payments • All grants are claimable quarterly in arrears • Claims can only be made for costs incurred and defrayed (amounts actually paid, may include partial payments) between the project start and end dates • All claims will be subject to an independent audit (including all academic partners) • In most cases audits are required with the first and last claim • Claims are only paid once quarterly reporting and necessary audits are complete • All projects are monitored on a quarterly basis including a visit from the appointed Monitoring Officer • The monitoring will be carried out against a detailed project plan
Update round 1 • Feasibility = 45 • Early Stage = 50 • Late Stage = 30 • Total grant request approx £100million • 1/3rd projects collaborative
email: helen.kuhlman@tsb.gov.ukmobile: +44 7748 328234twitter: @HelenKuhlman • competitions@innovateuk.org • Competition Helpline: 0300 321 4357 • Get involved • Follow us on twitter @innovate_uk or join the conversation using #BMC • Find innovators on _connect https:// https://connect.innovateuk.org • Visit www.innovateuk.org